加料方式对CuO/ZnO/Al2O3系催化剂前驱体性质的影响

用XRD、TG-DTG、TPR技术研究了不同加料方式对CuO/ZnO/Al2O3系催化剂前驱体物相组成及其结晶情况的影响，用加压微反装置考察了催化剂合成甲醇反应活性。结果表明, 加料方式对Cu2+形成的中间化合物的物相组成及结晶度影响显著,对Zn2+及Al3+的沉淀物相的影响很小。不同加料方式对催化剂前驱体物相组成及催化剂性能的影响主要是形成的初始前驱体中Cu的物相及结晶度不同。正加法主要形成Cu2(OH)3NO3,并流法主要形成无定形Cu2CO3(OH)2,后者与Zn5(CO3)2(OH)6相互作用转化为(Cu,Zn)2CO3(OH)2和（Cu,Zn）5(CO3)2(OH)6，由它们分解形成的CuO-ZnO固溶体是合成甲醇反应的活性相。并流法能最大程度的形成CuO-ZnO固溶体，有利于CuO粒子的细化，其催化活性较好。     

Electrochemical Characteristics of Mg0.9Ti0.1-xZrxNi （x=0.02, 0.04, 0.06） Alloys

Mg-based hydrogen storage alloys Mg0.9Ti0.1-xZrxNi (x=0.02, 0.04, 0.06) were successfully prepared by means of mechanical alloying (MA). The effects of Zr addition on the discharge capacity and the cycle performance of the Mg-based electrodes were also studied. It was found that the discharge capacities were improved with addition of a small amount of Zr and the cycle performances of the alloy were stabilized with the addition of Ti. The effects of surface modification or coating on the properties of Mg0.9Ti0.06Zr0.04Ni were also studied. The results indicated that coating with graphite improved both the discharge capacity and cycle life of the amorphous Mg0.9Ti0.06Zr0.04Ni electrode.     

改性离子液体中异丁烷与丁烯的烷基化反应

向由无水三氯化铝和盐酸三乙基胺合成的离子液体中溶入不同过渡金属（铜、铁、锌等）离子，考察它们对离子液体催化异丁烷与丁烯烷基化反应性能的影响。结果表明：过渡金属离子的加入能不同程度地影响离子液体的催化性能。溶入Cu2+和Cu+后，离子液体的催化性能有显著的改善，当Cu2+的摩尔加入量为三氯化铝的5%时，烷基化油收率达到丁烯体积的178%，对C8的选择性为75%，烷基化油辛烷值（RON）为92.2，并且离子液体可以重复使用。     

磁载纳米TiO2光催化剂的制备及其光催化性能研究

采用肼((NH2)2*H2O)还原硝酸铁(Fe(NO3)3)法制备纳米级磁基体(Fe3O4), 以聚乙二醇对其表面进行改性, 通过溶胶-凝胶法制得TiO2/Fe3O4磁载纳米TiO2光催化剂, 并用于光催化降解橙黄-II, 对其活性进行评价. 结果表明 TiO2/Fe3O4光催化剂的降解率在第一次使用时与纯TiO2相近, 三次循环使用后, 仍能保持较高的催化活性. 催化剂的最佳用量为4 g/L, 在酸性和碱性环境中均能保持很好的催化活性.     

N－乙酰皮考林酰肼合镍配合物的合成和晶体结构

合成了N－乙酰皮考林酰肼α-(C_5H_4N)CONHNHCOCH_3(简写为HL）及其镍配合 物Ni~(II)L_2·1.5CH_3OH·H_2O(C_(17.5)H_(24-)N_6NiO_(6.5))。配合物晶体属 于单斜晶系，空间群为P2_1/c，a = 1.5393 (1) nm, b = 0.80278(7) nm, c = 1. 8245(1) nm, β = 105.985(3)°, V=2.1674(3)nm~3, Z = 4, F(000) = 1004, R = 0.0503。在配合物中，镍（II）原子呈扭曲的N_4O_2八面体配位构型，晶体通 过分子间氢健作用形成一维的无限链状结构。红外光谱表明，配体在形成配合物后 , v (C=O)和v（C＝N）红移，电子光谱表明存在π-π~*和d-π~*的跃迁。     

Synthesis and properties of the copper(Ⅱ) complexes with stable radical

Four novel copper(Ⅱ) complexes have been synthesized,namely Cu(hfac)2NITPhNO2 (1),Cu(hfac)2NITPhCH3 (2),Cu(pfpr)2NITPhNO2,(3) and Cu(Pfpr)2NITPhCH3 (4),where hfac= hexafluoro-acetylacetonate,pfpr=pentafluoropropionate,NITR.=2-R-4,4,5,5-tetraniethyl-4,5-dihydro-1H-imidazolyl-1-oxyl-3-oxide.(R=4-nitrophenyl,4-methylphenyl).These complexes were rharicter-ized by elemental analyses,IR,electronic spectra and molar conductance.The temperature-dependent magnetic susceptibility of complexes 1 and 3 have been studied in the 4 300 K range,giving I he exchange integral J=10.56 cm-1 for complex 1 and J =-30.9 cm-1 for complex 3.     

磷脂酶A2家族的功能性分类研究

采用“结合强度指纹图谱分析”方法, 通过对多重分子对接得到的作用强度数据进行聚类矩阵分析对蛋白质进行功能分类. 着重研究了磷脂酶A₂家族基于抑制剂作用强度的功能分类, 并且与基于序列的聚类结果进行比较, 成功地解决了序列比对方法不能处理的远源蛋白(cPLA₂)的分类问题.     

Synthesis and Crystal Structur of (4,4''-H2bipy)[CdBr4]·H2O

The title compound (4,4'-H2bipy)[CdBr4]·H2O 1 has been synthesized via hydrothermal reaction and characterized by X-ray diffraction. The crystal belongs to monoelinic,space group P21/c with a=8.260(3), b=23.926(7), c=9.774(2) (A), β=106.777(9)°,C10H12Br4CdN2O, Mr=608.26, V=1849.4(9)(A)3, Z=4, Dc=2.185 g/cm3, S=1.005, μ(MoKα)=9.814 mm-1, F(000)=1128, R=0.0646 and wR=0.0989. The crystal structure analysis of 1reveals that the title compound features an isolated structure, based on discrete 4,4'-H2bipy moieties and lattice water molecules which are linked by hydrogen bonds together with tetrahedral cadmium atoms terminally coordinated by four bromine atoms.     

应用高分子铂络合物催化合成硅烷偶联剂

以二氧化硅为载体的侧链上含有配位基团和-COOH的聚硅氧烷(1-5)分别与氯铂酸反应制备了五种聚硅氧烷-铂络合物(“St-Pt-l”—“St-Pt-5”).这些高分子铂络合物,用于催化环氧丙基烯丙基醚与三甲及基氢硅烷反应具有很高的催化活性,在温和的条件下(80℃,30min),反应以72—98％的产率生成了硅烷偶联剂γ-(2,3-环氧丙氧基)丙基三甲氧基硅烷.通过对含,配位基的高分子铂络合物“Si-Pt-1”的稳定性研究,发现它可以重复使用多次而不降低其催化活性.     

3, 6-二取代-均三唑并[3, 4-b]-1, 3, 4-噻二唑的合成

研究了2-苯基-1, 2, 3-三唑-4-羧酸(1)与3-烷基/芳基-4-氨基-5-巯基-1, 2, 4-三唑(2a～o)在POCl~3催化下, 脱水缩合得到15个新的3-烷基/芳基-6-(2'-苯基-1', 2', 3'-三唑-4'-基)均三唑并[3,4-b]-1, 3, 4-噻二唑类化合物(3a～o)。